Acute Platelet Activation Induced by Smoking Cigarettes: In Vivo and Ex Vivo Studies in Humans

  • Kai G. Schmidt
  • Jens W. Rasmussen
  • Vagn Bonnevie-Nielsen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 273)


The epidemiological and pathological evidence for a relationship between cigarette smoking and atherosclerosis is considerable (1). In particular, a strong correlation between cigarette smoking and acute cardiac events in those with an already compromised coronary circulation is evident (2). As platelets seem to play a central role for the development of atherosclerosis and its thromboembolic complications (3), it is natural that a vivid interest has been taken in the effects of cigarette smoking on platelet function.


Platelet Activation Platelet Function Autologous Platelet Acute Cardiac Event Splenic Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis, 40: 1–52 (1981).PubMedCrossRefGoogle Scholar
  2. 2.
    Kannel WB. Cigarettes, coronary occlusions and myocardial infarction. JAMA, 246: 871–2 (1981).PubMedCrossRefGoogle Scholar
  3. 3.
    Schwartz CJ, Valente AJ, Kelley JL, Sprague EA, Edwards EH. Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Hemostas, 14: 189–95 (1988).CrossRefGoogle Scholar
  4. 4.
    Pittilo RM. Smoking and platelet-vessel wall interactions. In: Pittilo RM and Machin SJ (eds.). Platelet-vessel wall interactions. Springer-Verlag, pp 87–101 (1988).Google Scholar
  5. 5.
    FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J, 115: 267–71 (1988).PubMedCrossRefGoogle Scholar
  6. 6.
    Schmidt KG, Rasmussen JW. Acute platelet activation induced by smoking. In vivo and ex vivo studies in humans. Thromb Haemostas, 51: 279–82 (1984).Google Scholar
  7. 7.
    Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med, 195: 573–7 (1976).CrossRefGoogle Scholar
  8. 8.
    Wadenvik H, Kutti J. The effect of an adrenaline infusion on the splenic blood flow and intrasplenic platelet kinetics. Br J Haematol, 67: 187–92 (1987).PubMedCrossRefGoogle Scholar
  9. 9.
    Peters AM, Lavender JP. Factors controlling the intrasplenic transit of platelets. Eur J Clin Invest, 12: 191–5 (1982).PubMedCrossRefGoogle Scholar
  10. 10.
    Schmidt KG, Rasmussen JW, Rasmussen AD, Arendrup H. Comparative studies of the in vivo kinetics of simultaneously injected In-111- and Cr-51-labelled human platelets. Scand J Haematol, 30: 465–78 (1983).CrossRefGoogle Scholar
  11. 11.
    Brezinski DA, Tofler GH, Muller JE, Pohjola-Sintonen S, Willich SN, Schafer AI, Czeisler C, Williams GH. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation, 78: 35–40 (1988).PubMedCrossRefGoogle Scholar
  12. 12.
    Ardlie NG, McGuiness JA, Garrett JJ. Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis, 58: 251–9 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    Hollister AS, FitzGerald GA, Nadeau JHJ, Robertson D. Acute reduction in human platelet α2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines. J Clin Invest, 72: 1498–1505 (1983).PubMedCrossRefGoogle Scholar
  14. 14.
    Rohrer TF, Pfister B, Weber C, Imholf PR, Stucki P. Validity of the Wu-Hoak method for quantitative determination of platelet aggregation in vivo. Blut, 36: 15–20 (1978).PubMedCrossRefGoogle Scholar
  15. 15.
    Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood, 57: 199–202 (1981).PubMedGoogle Scholar
  16. 16.
    Goodwin DA, Bushberg Jt, Doherty PW, Lipton MJ, Conley FK, Dimanti CI, Meares CF. Indium-111- labeled autologous platelets for location of vascular thrombi in humans. J Nucl Med, 19: 626–34 (1978).PubMedGoogle Scholar
  17. 17.
    Pittilo RM, Clarke JMf, Harris D, Mackie IJ, Rowles PM, Machin SJ, Woolf N. Cigarette smoking and platelet adhesion. Br J Haematol, 58: 627–32 (1984).PubMedCrossRefGoogle Scholar
  18. 18.
    Rival J, Riddle JM, Stein PD. Effects of chronic smoking on platelet function. Thromb Res, 45: 75–85 (1987).PubMedCrossRefGoogle Scholar
  19. 19.
    Wennmalm Å. Interaction of nicotine and prostaglandins in the cardiovascular system. Prostagl, 23: 139–44 (1982).CrossRefGoogle Scholar
  20. 20.
    Madsen H, Dyerberg J. Cigarette smoking and its effects on the platelet-vessel wall interaction. Scand J Clin Lab Invest, 44: 203–6 (1984).PubMedCrossRefGoogle Scholar
  21. 21.
    Kenney MW, George AJ, Stuart J. Platelet hyperactivity in sicklecell disease: a consequence of hyposplenism. J Clin Pathol, 33: 622–5 (1980).CrossRefGoogle Scholar
  22. 22.
    Robinette CD, Fraumeni JF. Splenectomy and subsequent mortality in veterans of the 1939–45 war. Lancet, 2: 127–9 (1977).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Kai G. Schmidt
    • 1
  • Jens W. Rasmussen
    • 1
  • Vagn Bonnevie-Nielsen
    • 1
  1. 1.Department of Nuclear Medicine and Department of Clinical ChemistryOdense University HospitalDenmark

Personalised recommendations